SomnoMed Limited reported sales results for the month, second quarter and six months ended December 2014. Sales in December 2014 were over 5,000 units.

The company reported second quarter of fiscal 2015 sales of 13,575 units. Strong growth was achieved in the US during the second quarter, which saw unit sales increase by over 30% compared to the same quarter in the previous year, and resulted in global volume growth for the second quarter of 21.8%. Total revenues generated in the first half of the financial year grew by 18% to $14.81 million.

For the first half, sales totaled 24,775 units. Total revenues generated in the first half of the financial year grew by 18% to $14.81 million.

As previously indicated, profit growth in the first half of fiscal 2015 will be lower than the growth in revenues, with start-up costs incurred in new markets in Europe and Asia, and expenditure relating to the global launch of new products.

Guidance for the second half was based on the expectation of a further acceleration of its growth rates in volumes and revenues, leading to total sales of 30,000 units and revenues in the order of $18 million during the January to June 2015 period. This would result in volume growth of 30% in the second half and 26% for the year being achieved. Profits in the second half are likely to be in line with its expectations and will give an indication of the future earnings capability of SomnoMed.

The company confirmed the forecast revenues of $32.5 million for the financial year of fiscal 2015. Given first half earnings, EBITDA for the year is expected to be consistent with its guidance but likely to come in towards the lower end of the range given.